Centro Médico Teknon
Jaume Capdevila












| Turkey | Austria | Barcelona | |
|---|---|---|---|
| Immunotherapy | from $2,500 | ≈ $9,000 | from $4,400 |
| Sarcoma Immunotherapy | from $8,900 | ≈ $18,000 | from $6,000 |
| Immunotherapy with Keytruda (Pembolizumab) | from $2,800 | ≈ $5,800 | from $13,500 |
| Immunotherapy for prostate cancer | from $8,000 | ≈ $9,500 | from $6,000 |
| Immunotherapy for lung cancer | from $8,000 | ≈ $5,800 | from $5,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.

























Day 1
Day 2
Day 3
Day 4
Day 5 to Day 7
Week 2
Week 3
Week 4
Please note that each patient"s case is unique and the above schedule can change depending on the patient"s health condition and response to the treatment.

Dr. Jaume Capdevila is a medical oncologist at Teknon Medical Center in Barcelona. He specializes in treating cancers of the digestive and endocrine systems. Dr. Capdevila is a co-founder of the Spanish Task Force Group for Orphan and Infrequent Tumors.

Dr. Graupera heads the Hematology Oncology Department at Sant Joan De Déu – one of Europe's top children's hospitals. His research focuses on pediatric cancer treatments.

Dr. Carlos Pollán leads the robotic head and neck surgery program at Centro Médico Teknon. He is a specialist in endoscopic skull base surgery and oncology. Dr. Pollán has performed over 430 operations. He uses the Da Vinci system for precise, minimally invasive procedures. Dr. Pollán trained at the University of Pittsburgh and the University Hospital of Pisa.

Dr. Javier Cortés Castán, MD, PhD, is a medical oncologist. He is the Director and Founder of the International Breast Cancer Center (IBCC) at Centro Médico Teknon (Quironsalud) in Barcelona. He has 25+ years of practice. He specializes in HER2‑positive and triple‑negative breast cancer. Expertscape ranks him #1 worldwide in HER2+.
He has authored 550+ publications and given 800+ presentations. He leads 150+ active clinical trials. His work helped enable 12 metastatic breast cancer treatments approved in Europe. He was a key leader in KEYNOTE‑522, KEYNOTE‑355, and DESTINY‑Breast03. He is the only Spanish oncologist with two papers in CA: A Cancer Journal for Clinicians. He is a 2026 Giants of Cancer Care honoree. IBCC provides advanced care and access to trials. Centro Médico Teknon is JCI‑accredited.




Written by Kateryna Zamkovska
Anna Leonova